Exelixis | EXEL - Pe Prix À Revenus





Pe Changement Date
Acadia Pharmaceuticals 11.33 1.25 2026-06
Agios Pharmaceuticals 3.56 0 2026-03
Akebia Therapeutics 1.63K 1.6K 2025-12
Amgen 18.07 1.77 2026-06
AstraZeneca 25.34 4.25 2026-06
Bayer 4.14 0.74 2026-06
BioMarin Pharmaceutical 21.07 5.79 2026-06
Bristol-Myers Squibb 16.14 7.06 2026-06
Eisai 26.55 9.06 2026-06
Eli Lilly 32.9 7.37 2026-06
Exelixis 18.02 4.11 2026-06
Genmab 16.04 1.05 2026-06
Glaxosmithkline 15.09 3.43 2026-03
Incyte 14.45 0.9 2026-06
Ionis Pharmaceuticals 396.15 79.28 2022-09
Merck 32.26 15.74 2026-06
Moderna 27.22 14.51 2023-06
Neurocrine Biosciences 22.1 5.99 2026-06
Novartis 22.41 2.24 2026-06
Pfizer 11.48 2.16 2026-06
Puma Biotechnology 13.93 44.88 2024-06
Sanofi 20.87 5.12 2026-03
Takeda 24.4 22.12 2026-06
Xencor 29.92 3.22 2022-09